NEW Product: MagBeads FastDNA™ Kit for Feces request your FREE sample

Login / Sign Up
Cart
 

Vincristine sulfate

Vincristine sulfate
€153.00

Key features and details

Vincristine Sulfate

SKU: 02190687-CF

Synonyms
22-oxo-vincaleukoblastine sulfate; Leuocristine sulfate (1:1); Vincrisul; VCR
CAS Number:
2068-78-2
Molecular Formula:
C46H58N4O14S
Molecular Weight:
923.044 g/mol
Beilstein Registry Number:
3924631
EC Number:
218-190-0
MDL Number:
MFCD00084729
Product Description

Vincristine Sulfate

Application Notes

Vincristine Sulfate is used to treat acute leukaemia, malignant lymphoma, Hodgkin′s disease, acute erythraemia, acute panmyelosis, breast cancer, Kaposi’s sarcoma and testicular cancer. It is widely used in cancer research. It is used to study multi-drug resistance. It is used to inhibit cell cycle progression at M-phase and to inhibit monoamine oxidase (MAO).

Usage Statement

Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.

Key Applications

Antitumor agent | Treatment of acute leukaemia; malignant lymphoma; Hodgkin′s disease; acute erythraemia; acute panmyelosis; Breast cancer

Specifications
SKU 02190687-CF
Alternate Names 22-oxo-vincaleukoblastine sulfate; Leuocristine sulfate (1:1); Vincrisul; VCR
Application Notes Vincristine Sulfate is used to treat acute leukaemia, malignant lymphoma, Hodgkin′s disease, acute erythraemia, acute panmyelosis, breast cancer, Kaposi’s sarcoma and testicular cancer. It is widely used in cancer research. It is used to study multi-drug resistance. It is used to inhibit cell cycle progression at M-phase and to inhibit monoamine oxidase (MAO).
Base Catalog Number 190687
Beilstein Registry Number 3924631
Biochemical Physiological Actions Vincristine is a plant alkaloid that inhibits microtubule assembly by binding tubulin and inducing coiled spiral aggregate formation. It arrests cell cycle in G2/M-phase by blocking mitotic spindle formation. Vincristine triggers Raf-1 activation, phosphorylation of bcl-2-family proteins, induction of p53 expression, and apoptosis in several tumor cell lines. It inhibits VEGF production in leukemia cell lines. It is a substrate for Pgp and CYP3A4. MRP1 transports vincristine in an ATP- and GSH-dependent manner. Vincristine has some immunosuppressant effect. Vincristine may also interfere with amino acid, cyclic AMP, and glutathione metabolism, calmodulin-dependent Ca2+-transport, cellular respiration, and nucleic acid and lipid biosynthesis.
CAS # 2068-78-2
EC Number 218-190-0
Format Powder
Hazard Statements H300-H341-H361fd
Melting Point 531° F approximately (NTP, 1992)
Molecular Formula C46H58N4O14S
Molecular Weight 923.044 g/mol
RTECS Number OH6340000
Safety Symbol GHS06, GHS08
Solubility greater than or equal to 10 mg/mL at 75° F (NTP, 1992)
Usage Statement Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Documents

Certificate of Analysis (COA)

Datasheet

Datasheet

Safety Data Sheets

English (United States)